Retinoblastoma 94 enhances radiation treatment of esophageal squamous cell carcinoma in vitro and in vivo

Journal of Radiation Research

Volumn 53, Issue 1, 2012, Pages 117-124

  Zhang, Heng ^a   Li, Jin ^a   Wang, Yue Ying ^a   Meng, Ai Min ^a   Liu, Qiang ^a   Wang, Lei ^a   Chen, Feng Hua ^a   Wang, Xiao Chun ^a   Zhai, Zhi Bin ^a   Fu, Yue ^a   Wang, Qin ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CELL DEATH; GENE EXPRESSION; GENE TRANSFER; IONIZING RADIATION; POLYMERASE CHAIN REACTION; RADIOTHERAPY; TUMORS;

CELL APOPTOSIS; CELL CYCLE; CELL LINES; CYCLE DISTRIBUTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; IN-VITRO; RADIATION TREATMENTS; RETINOBLASTOMA; TRANSFER CANS; VITRO AND IN VIVO;

CELL CULTURE;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 84863296211     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11051     Document Type: Article

References (32)

1. Ando N, et al (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2): 225-232. (Pubitemid 30616724)
2. Ke L (2002) Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 102(3): 271-274. (Pubitemid 35222298)
3. Nabeya Y, et al (2005) Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Dis Esophagus 18(6): 388-397. (Pubitemid 43904767)
4. Rosen EM, et al (1999) The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Invest 17(1): 56-72. (Pubitemid 29072680)
5. Sellers WR and Kaelin WG Jr (1997) Role of the retinoblas-toma protein in the pathogenesis of human cancer. J Clin Oncol 15(11): 3301-3312. (Pubitemid 27485848)
6. Cairns P, Proctor AJ and Knowles MA (1991) Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6(12): 2305-2309. (Pubitemid 21924078)
7. Chou NH, et al (2006) Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma. World J Gastroenterol 12(44): 7188-7191.
8. Contu SS, et al (2007) pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus. World J Gastroenterol 13(11): 1728-1731. (Pubitemid 46711346)
9. Hui AM, et al (1999) Over-expression and lack of retinoblas-toma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 84(6): 604-608.
10. Varley JM, et al (1989) The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 4(6): 725-729. (Pubitemid 19150653)
11. Xu HJ, et al (1994) Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc Natl Acad Sci USA 91(21): 9837-9841.
12. Xu HJ, et al (1996) Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res 56(10): 2245-2249.
13. Knudsen KE, et al (1999) Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest. J Biol Chem 274(39): 27632-27641.
14. Lukas J, et al (1997) Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev 11(11): 1479-1492. (Pubitemid 27259857)
15. Araki K, et al (2008) Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma. Clin Cancer Res 14(11): 3514-3519.
16. Li D, et al (2002) The role of adenovirus-mediated retinoblas-toma 94 in the treatment of head and neck cancer. Cancer Res 62(16): 4637-4644.
17. Roig JM, et al (2000) Adenovirus-mediated retinoblastoma 94 gene transfer induces human pancreatic tumor regression in a mouse xenograft model. Clin Cancer Res 10(4): 1454-1462.
18. TM Clone Technology. Cancer Research on Prevention and Treatment 37: 1-5.
19. Katzenberger T, et al (2006) The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lym-phoma. Blood 107(8): 3407.
20. Morimoto R, et al (2008) Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J 55(1): 49-55.
21. Soomro IN, Holmes J and Whimster WF. Predicting prognosis in lung cancer: use of proliferation marker, Ki67 monoclonal antibody. J Pak Med Assoc 48(3): 66-69.
22. Weigel MT and Dowsett M (2010) Current and emerging bio-markers in breast cancer: prognosis and prediction. Endocr Relat Cancer 17(4): 245-262
23. Classon M and Harlow E (2002) The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2(12): 910-917. (Pubitemid 37328892)
24. Lipinski MM and Jacks T (1999) The retinoblastoma gene family in differentiation and development. Oncogene 18(55): 7873-7882. (Pubitemid 30066233)
25. Knudsen KE, et al (2000) RB-dependent S-phase response to DNA damage. Mol Cell Biol 20(20): 7751-7763.
26. Rigberg DA, et al (1999) Hypophosphorylated retinoblastoma protein is associated with G2 arrest in esophageal squamous cell carcinoma. J Surg Res 84(1): 101-105. (Pubitemid 29391608)
27. Welch PJ and Wang JY (1993) A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75(4): 779-790. (Pubitemid 23346375)
28. Kharbanda S, et al (1996) The stress response to ionizing radiation involoves c-Abl-dependent phosphorylation of SHPTP1. Proc Natl Acad Sci USA 93(14): 6898-6901. (Pubitemid 26243471)
29. Yuan ZM, et al (1997) Inhibition of phosphatidylinositol 3-kinase by c-Abl in the genotoxic stress response. J Biol Chem 272(38): 23485-23488.
30. Bowen C, Birrer M and Gelmann EP (2002) Retinoblastoma protein-mediated apoptosis after gamma-irradiation. J Biol Chem 277(47): 44969-44979.
31. Shim J, et al (2000) Rb protein down-regulates the stress-activated signals through inhibiting c-Jun N-terminal kinase/ stress-activated protein kinase. J Biol Chem 2000(19); 275: 14107-14111. (Pubitemid 30339686)
32. Chen YR, et al (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271(50): 31929-31936.